Amlexanox
Amlexanox is an anti-inflammatory compound that adds metabolic resilience by addressing leptin resistance and fat partitioning. Originally FDA-approved for treating canker sores, it has been repurposed in peptide protocols for its metabolic and anti-inflammatory properties. Anti-inflammatory agent that helps with leptin resistance and fat partitioning. Inhibits IKKe and TBK1, two kinases involved in inflammation and energy storage (PMID: 23396211); in a randomized trial, amlexanox improved glucose control in a subset of patients with type 2 diabetes (PMID: 28683283). Adds metabolic resilience when combined with other fat-loss peptides. Helps the body respond better to weight loss signals. - Anti-inflammatory metabolic support
This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.
Stacks containing Amlexanox
What bloodwork do I need?
Reference ranges are general guidelines. Consult your physician for interpretation.
- CMP
- CBC
- Lipid Panel
- Fasting Glucose
- Fasting Insulin
- HbA1c
- CRP
- CMP
- Fasting Glucose
- CRP
- CMP
- Lipid Panel
- Fasting Glucose
- HbA1c
Safety & Regulatory Status
Regulatory status for Amlexanox may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.